Matrix Metalloproteinase Inhibition During the Development of Congestive Heart Failure : Effects on Left Ventricular Dimensions and Function

Circulation Research- United States

doi 10.1161/01.res.85.4.364

Full Text

Abstract

Available in

Categories

Cardiovascular Medicine

Date

August 20, 1999

Authors

Francis G. Spinale

Stephen R. Krombach

Rupak Mukherjee

Scott B. Kribbs

Linda L. Johnson

J. Thomas Peterson

Michael R. Zile

Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Selective Matrix Metalloproteinase Inhibition With Developing Heart Failure: Effects on Left Ventricular Function and Structure

Circulation Research

Cardiovascular Medicine

English

Impact of Treatment of Sleep Apnoea on Left Ventricular Function in Congestive Heart Failure

Respiratory Medicine

English

Left Ventricular Noncompaction and Congenital Heart Disease Increases the Risk of Congestive Heart Failure

Journal of Clinical Medicine

English

Matrix Metalloproteinase Therapy in Heart Failure

Current Treatment Options in Cardiovascular Medicine

Cardiovascular Medicine

English

Physiological Replacement of T3 Improves Left Ventricular Function in an Animal Model of Myocardial Infarction-Induced Congestive Heart Failure

Circulation. Heart failure

Cardiovascular Medicine

English

An Electromechanical Left Ventricular Wedge Model to Study the Effects of Deformation on Repolarization During Heart Failure

BioMed Research International

Molecular Biology

English

Testosterone and Left Ventricular Diastolic Function in Men With Heart Failure.

Cardiologia Croatica

Cardiovascular Medicine

English

Thromboxane Inhibition Improves Renal Perfusion and Excretory Function in Severe Congestive Heart Failure

Journal of the American College of Cardiology

Cardiovascular Medicine

English

How Do Beta-Blockers Improve Ventricular Function in Patients With Congestive Heart Failure?

Cardiovascular Medicine

English